Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Battegay

Showing results (1-10 of 211) with videos related to

Pageof 22
Sort By:
Hepatology (Baltimore, Md.)|October 1, 1996
Immunity to hepatitis C virus: a further piece of the puzzleM Battegay
Praxis|May 28, 1997
[Can HIV/AIDS be healed with new therapies?]M Battegay
Expert Opinion on Investigational Drugs|February 15, 2001
Critical issues of HIV treatment in the era of highly active antiretroviral therapyM Battegay
Der Internist|April 26, 2008
[Commentary on the STROBE statement. A checklist for observational studies improves transparency]M Battegay
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|August 29, 1998
Human immunodeficiency virus mutation and changes in CD4 T-cell levels during antiretroviral therapyM Battegay
The New England Journal of Medicine|December 29, 1998
Lamivudine for chronic hepatitis BE Bernasconi, M Battegay
Der Internist|April 2, 2005
[Clinical study of infectious diseases. An interdisciplinary challenge in medicine]U Flückiger, M Battegay
Der Internist|December 23, 2003
[Therapy of severe fungal infections]M Battegay, U Flückiger
Praxis|June 5, 2001
[Generalized lymphadenopathy in a 43-year-old patient]R Stöckli, M Battegay
Therapeutische Umschau. Revue Therapeutique|June 27, 1998
[Clinically significant drug interactions in HIV-infected patients]M Weisser, M Battegay
Pageof 22

Showing results (1-10 of 211) with videos related to

Sort By:
Pageof 22
Hepatology (Baltimore, Md.)|October 1, 1996
Immunity to hepatitis C virus: a further piece of the puzzleM Battegay
Praxis|May 28, 1997
[Can HIV/AIDS be healed with new therapies?]M Battegay
Expert Opinion on Investigational Drugs|February 15, 2001
Critical issues of HIV treatment in the era of highly active antiretroviral therapyM Battegay
Der Internist|April 26, 2008
[Commentary on the STROBE statement. A checklist for observational studies improves transparency]M Battegay
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|August 29, 1998
Human immunodeficiency virus mutation and changes in CD4 T-cell levels during antiretroviral therapyM Battegay
The New England Journal of Medicine|December 29, 1998
Lamivudine for chronic hepatitis BE Bernasconi, M Battegay
Der Internist|April 2, 2005
[Clinical study of infectious diseases. An interdisciplinary challenge in medicine]U Flückiger, M Battegay
Der Internist|December 23, 2003
[Therapy of severe fungal infections]M Battegay, U Flückiger
Praxis|June 5, 2001
[Generalized lymphadenopathy in a 43-year-old patient]R Stöckli, M Battegay
Therapeutische Umschau. Revue Therapeutique|June 27, 1998
[Clinically significant drug interactions in HIV-infected patients]M Weisser, M Battegay
Pageof 22